In the United States, the complementary and integrative medicine dialogue about “traditional medicine” typically looks to Asia. The West-meets-East orientation respects the power and influence of Chinese and Indian traditions. Yet in doing so, both local indigenous practices and the roles of traditional, complementary and integrative medicine (TCIM) in Mexico, Central America, South America and the Caribbean are mostly overlooked. The Pan American Health Organization (PAHO) recently created a partial remedy for this hemispheric forgetfulness. A two-year collaborative process with representatives of over 20 nations has created a powerful network and opened access to a nation-by-nation bounty of practices, papers, research, and regulations.
For the past half decade, the Academy of Integrative Pain Management (AIPM) has carried the policy mantle for integrative pain treatment into ever more influential places. The beacons were the 2017 and 2018 Integrative Pain Care Policy Congress. The most recent convened 70 stakeholder organizations, including key payers and federal agencies. On January 29, 2019, AIPM announced that it has ceased operations. Amidst the present opportunities for transforming pain treatment, the integrative pain field lost its engine. Oddly, the very challenges to the pharma industry in the center of the dominant pain model were part of AIPM’s undoing.
An organization that sees its mission as larger than its present reach hits natural barriers if it uses an association management firm. The management organization is not an “association growing” firm. Nor is the firm devoted solely to the association. In fact, the management firm’s financial incentive structure is akin to that of a fitness center: the best member is one who pays dues and never requires anything. It’s job is to manage and control something that, optimally is passionate, dynamic, and slightly out of control because it is actively flourishing in multiple directions. These disparate tendencies came to mind as good news arrived December 21, 2018 – Solstice Day – that arguably the most powerful engine in the integrative space, the Academic Consortium for Integrative Medicine and Health (“the Consortium”), completed a transition away from an association management firm to its first, 100% time, fully devoted executive director.
At one point over the past three years of robust expansion of dialogue related to chronic pain care I received a somewhat panicky email from an integrative care advocate. He was concerned that by me speaking of the “opportunity” for integrative health produced by the US’ enthrallment with opioids that his field would be tainted as “opportunists.” Fact is, the dialogue over right use of “non-pharmacologic” practices and practitioners in chronic pain treatment has provoked a quantum opening in many quarters. This article shares an invitation to a December 4-5 workshop at from the National Academy Medicine (NAM) – the most robust inclusion of integrative health there since the 2009 Summit. Also included: another positive development at NAM, and first notes of advances at AIPM’s recent Integrative Pain Care Policy Congress. The bad news of the opioid crisis is proving very good for opening needed dialogue.